undamentalytics Newsletter

Dare Bioscience vs Shattuck Labs

Dare Bioscience and Shattuck Labs are similar in size: $1.0m and $1.0m of revenue in their latest fiscal years. Dare Bioscience grew faster (10429.4% against -82.5%). Dare Bioscience kept more of each dollar of sales as profit: a net margin of -1300.7% against -4880.9%. Dare Bioscience carries less debt relative to equity (0.0% against 0.0%).

Latest fiscal yearDare BioscienceDARE, 2025Shattuck LabsSTTK, 2025
Revenue $1.0m $1.0m
Revenue growth 10429.4% -82.5%
Net income −$13.4m −$48.8m
Operating margin -1315.5% -5150.8%
Net margin -1300.7% -4880.9%
Return on equity — -60.3%
Free cash flow −$10.3m −$40.0m
Cash $24.7m $54.2m
Total debt $0 $0
Debt to equity 0.0% 0.0%
Dividend per share — —
Dividend yield — —
Share buybacks — —
Employees 24 40
Market value $9.9m $536m
Price vs our value range — —
Moat score — 12 (Weak)
Insider trades, 12 months 0 buys, 0 sales 1 buys, 6 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.